
Essential fatty acids in the diet such as omega-3 and omega-6 play a major role in regulating gene coding for secreted proteins in the muscles, reveals a new study published in Physiological Genomics.
Alpha-linolenic acid (ALA) and linoleic acid (LA) are plant-based essential fats called polyunsaturated fatty acids (PUFA) that humans consume through diet.
Advertisement
‘Obesity has a greater impact on skeletal muscle gene expression. Alpha-linolenic acid (ALA) and linoleic acid (LA) may regulate the skeletal muscle secretome differentially.’
Tweet it Now
ALA is an omega-3 fatty acid; LA is an omega-6 fatty acid. Omega-3 and omega-6 fatty acids have been shown to be beneficial to brain health and reduce the risk of inflammation and heart disease.
Previous studies have shown that proteins secreted from the muscles (skeletal muscle secretome) help regulate signaling of metabolic activities such as muscle fiber formation and the function of insulin-producing beta cells in the pancreas.
This prior research suggests that obesity and insulin resistance, an inability of the body to properly respond to insulin changes the skeletal muscle secretome.
A research team from the University of Guelph in Ontario, Canada, explored how regular consumption of essential fats regulates how genes use information (gene expression) associated with the skeletal muscle secretome.
The researchers studied glucose levels and took samples from muscle and RNA, a molecule chain that uses genetic information from DNA to produce proteins in the cells from four groups of rats:
In addition, the researchers found more than 135 genes that expressed differently based on diet among the four groups of animals, including genes that correspond with 15 secreted proteins. Expression in most of these proteins differed between the lean and obese groups.
These results suggest that "LA and ALA may differentially regulate the skeletal muscle secretome," the researchers explained, and that the addition of PUFA further alters gene expression.
"Our findings concerning the relationship between obesity and the skeletal muscle secretome add valuable information to a relatively understudied area of investigation."
Source: Eurekalert
Advertisement
This prior research suggests that obesity and insulin resistance, an inability of the body to properly respond to insulin changes the skeletal muscle secretome.
A research team from the University of Guelph in Ontario, Canada, explored how regular consumption of essential fats regulates how genes use information (gene expression) associated with the skeletal muscle secretome.
The researchers studied glucose levels and took samples from muscle and RNA, a molecule chain that uses genetic information from DNA to produce proteins in the cells from four groups of rats:
- A lean group ate a normal diet ("lean")
- An obese group ate food supplemented with ALA ("ALA")
- An obese group ate food supplemented with LA ("LA") and
- An obese control group ate a normal diet ("obese control")
In addition, the researchers found more than 135 genes that expressed differently based on diet among the four groups of animals, including genes that correspond with 15 secreted proteins. Expression in most of these proteins differed between the lean and obese groups.
These results suggest that "LA and ALA may differentially regulate the skeletal muscle secretome," the researchers explained, and that the addition of PUFA further alters gene expression.
"Our findings concerning the relationship between obesity and the skeletal muscle secretome add valuable information to a relatively understudied area of investigation."
Source: Eurekalert
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Obesity News

Researchers examine the role of unknown protein NOTCH2-associated receptor2 (MINAR2) in obesity and diabetes using generated Minar2 knockout (KO) mice.

Study reports that body contouring after bariatric surgery does not contribute to long-term weight loss in patients with massive weight loss.

Recently FDA-approved drug semaglutide has proven as a highly effective anti-obesity medication showcasing remarkable weight loss benefits.

Gut bacteria profile and abundance in toddlers can serve as a predictive factor for their body mass index (BMI) at age 5, irrespective of premature birth status.

Obese individuals were found to have weaker appetite regulation, with factors that inhibit eating behavior.